Sensitive and selective analysis of a wide concentration range of IGFBP7 using a surface plasmon resonance biosensor

Dae Ho Jang, Youngbo Choi, Yong Soo Choi, Sun Mi Kim, Hojung Kwak, Sehyun Shin, Surin Hong

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A sensitive method for selectively detecting insulin-like growth factor-binding protein 7 (IGFBP7) over a wide range of concentrations based on the surface plasmon resonance (SPR) biosensing techniques is described. IGFBP7 has been shown to regulate cell proliferation, cell adhesion, cellular senescence, apoptosis, and angiogenesis in several different cancer cell lines. Since the concentration of IGFBP7 can vary widely in the body, determining the precise concentration of IGFBP7 over a wide range of concentrations is important, since it serves as an inducible biomarker for both disease diagnosis and subsequent therapy. The SPR sensing method is based on the selective interaction of IGFBP7 with specific anti-IGFBP7 proteins on a gold thin film, which was covalently bound to the Fc-binding domain of protein G on a mixed self-assembled monolayer composed of DSNHS (S2(CH2)11COO(CH2)2COO-(N-hydroxysuccinimide)) and mercaptoundecanol, and effect of this on changes in the SPR profiles. The limit of detection (LOD) of the SPR biosensor was determined to be 10ng/ml, which is a reasonable LOD value for biomedical applications. The response is essentially linear in the concentration range of 10-300ng/ml. The SPR biosensor also shows specificity for IGFBP7 compared to that for biologically relevant interleukin (IL) derivatives including IL4, IL23, IL29, and IFG1. These molecules are also present along with IGFBP7 in the cell culture medium and have the potential to interfere with the analysis. Finally, the level secretion of IGFBP7 from cancer cells detected by the SPR biosensor showed a good correlation with a commercial kit using an IGFBP7 enzyme-linked immunosorbent assay. The findings reported herein indicate that the SPR biosensor for IGFBP7 would be applicable in a wide variety of biomedical fields.

Original languageEnglish
Pages (from-to)887-891
Number of pages5
JournalColloids and Surfaces B: Biointerfaces
Volume123
DOIs
Publication statusPublished - 2014 Nov 1

Fingerprint

insulin
Surface Plasmon Resonance
Insulin
Surface plasmon resonance
Biosensing Techniques
bioinstrumentation
surface plasmon resonance
Biosensors
proteins
Limit of Detection
Intercellular Signaling Peptides and Proteins
Carrier Proteins
insulin-like growth factor binding protein-related protein 1
Cells
Proteins
cancer
Immunosorbents
Cell Aging
interleukins
Interleukins

ASJC Scopus subject areas

  • Biotechnology
  • Colloid and Surface Chemistry
  • Physical and Theoretical Chemistry
  • Surfaces and Interfaces

Cite this

Sensitive and selective analysis of a wide concentration range of IGFBP7 using a surface plasmon resonance biosensor. / Jang, Dae Ho; Choi, Youngbo; Choi, Yong Soo; Kim, Sun Mi; Kwak, Hojung; Shin, Sehyun; Hong, Surin.

In: Colloids and Surfaces B: Biointerfaces, Vol. 123, 01.11.2014, p. 887-891.

Research output: Contribution to journalArticle

Jang, Dae Ho ; Choi, Youngbo ; Choi, Yong Soo ; Kim, Sun Mi ; Kwak, Hojung ; Shin, Sehyun ; Hong, Surin. / Sensitive and selective analysis of a wide concentration range of IGFBP7 using a surface plasmon resonance biosensor. In: Colloids and Surfaces B: Biointerfaces. 2014 ; Vol. 123. pp. 887-891.
@article{5efcc89cc0eb4acf81186e57d9be6860,
title = "Sensitive and selective analysis of a wide concentration range of IGFBP7 using a surface plasmon resonance biosensor",
abstract = "A sensitive method for selectively detecting insulin-like growth factor-binding protein 7 (IGFBP7) over a wide range of concentrations based on the surface plasmon resonance (SPR) biosensing techniques is described. IGFBP7 has been shown to regulate cell proliferation, cell adhesion, cellular senescence, apoptosis, and angiogenesis in several different cancer cell lines. Since the concentration of IGFBP7 can vary widely in the body, determining the precise concentration of IGFBP7 over a wide range of concentrations is important, since it serves as an inducible biomarker for both disease diagnosis and subsequent therapy. The SPR sensing method is based on the selective interaction of IGFBP7 with specific anti-IGFBP7 proteins on a gold thin film, which was covalently bound to the Fc-binding domain of protein G on a mixed self-assembled monolayer composed of DSNHS (S2(CH2)11COO(CH2)2COO-(N-hydroxysuccinimide)) and mercaptoundecanol, and effect of this on changes in the SPR profiles. The limit of detection (LOD) of the SPR biosensor was determined to be 10ng/ml, which is a reasonable LOD value for biomedical applications. The response is essentially linear in the concentration range of 10-300ng/ml. The SPR biosensor also shows specificity for IGFBP7 compared to that for biologically relevant interleukin (IL) derivatives including IL4, IL23, IL29, and IFG1. These molecules are also present along with IGFBP7 in the cell culture medium and have the potential to interfere with the analysis. Finally, the level secretion of IGFBP7 from cancer cells detected by the SPR biosensor showed a good correlation with a commercial kit using an IGFBP7 enzyme-linked immunosorbent assay. The findings reported herein indicate that the SPR biosensor for IGFBP7 would be applicable in a wide variety of biomedical fields.",
keywords = "Cellular secretion, IGFBP7, Sensitive detection, Specificity, Surface plasmon resonance biosensor",
author = "Jang, {Dae Ho} and Youngbo Choi and Choi, {Yong Soo} and Kim, {Sun Mi} and Hojung Kwak and Sehyun Shin and Surin Hong",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.colsurfb.2014.10.037",
language = "English",
volume = "123",
pages = "887--891",
journal = "Colloids and Surfaces B: Biointerfaces",
issn = "0927-7765",
publisher = "Elsevier",

}

TY - JOUR

T1 - Sensitive and selective analysis of a wide concentration range of IGFBP7 using a surface plasmon resonance biosensor

AU - Jang, Dae Ho

AU - Choi, Youngbo

AU - Choi, Yong Soo

AU - Kim, Sun Mi

AU - Kwak, Hojung

AU - Shin, Sehyun

AU - Hong, Surin

PY - 2014/11/1

Y1 - 2014/11/1

N2 - A sensitive method for selectively detecting insulin-like growth factor-binding protein 7 (IGFBP7) over a wide range of concentrations based on the surface plasmon resonance (SPR) biosensing techniques is described. IGFBP7 has been shown to regulate cell proliferation, cell adhesion, cellular senescence, apoptosis, and angiogenesis in several different cancer cell lines. Since the concentration of IGFBP7 can vary widely in the body, determining the precise concentration of IGFBP7 over a wide range of concentrations is important, since it serves as an inducible biomarker for both disease diagnosis and subsequent therapy. The SPR sensing method is based on the selective interaction of IGFBP7 with specific anti-IGFBP7 proteins on a gold thin film, which was covalently bound to the Fc-binding domain of protein G on a mixed self-assembled monolayer composed of DSNHS (S2(CH2)11COO(CH2)2COO-(N-hydroxysuccinimide)) and mercaptoundecanol, and effect of this on changes in the SPR profiles. The limit of detection (LOD) of the SPR biosensor was determined to be 10ng/ml, which is a reasonable LOD value for biomedical applications. The response is essentially linear in the concentration range of 10-300ng/ml. The SPR biosensor also shows specificity for IGFBP7 compared to that for biologically relevant interleukin (IL) derivatives including IL4, IL23, IL29, and IFG1. These molecules are also present along with IGFBP7 in the cell culture medium and have the potential to interfere with the analysis. Finally, the level secretion of IGFBP7 from cancer cells detected by the SPR biosensor showed a good correlation with a commercial kit using an IGFBP7 enzyme-linked immunosorbent assay. The findings reported herein indicate that the SPR biosensor for IGFBP7 would be applicable in a wide variety of biomedical fields.

AB - A sensitive method for selectively detecting insulin-like growth factor-binding protein 7 (IGFBP7) over a wide range of concentrations based on the surface plasmon resonance (SPR) biosensing techniques is described. IGFBP7 has been shown to regulate cell proliferation, cell adhesion, cellular senescence, apoptosis, and angiogenesis in several different cancer cell lines. Since the concentration of IGFBP7 can vary widely in the body, determining the precise concentration of IGFBP7 over a wide range of concentrations is important, since it serves as an inducible biomarker for both disease diagnosis and subsequent therapy. The SPR sensing method is based on the selective interaction of IGFBP7 with specific anti-IGFBP7 proteins on a gold thin film, which was covalently bound to the Fc-binding domain of protein G on a mixed self-assembled monolayer composed of DSNHS (S2(CH2)11COO(CH2)2COO-(N-hydroxysuccinimide)) and mercaptoundecanol, and effect of this on changes in the SPR profiles. The limit of detection (LOD) of the SPR biosensor was determined to be 10ng/ml, which is a reasonable LOD value for biomedical applications. The response is essentially linear in the concentration range of 10-300ng/ml. The SPR biosensor also shows specificity for IGFBP7 compared to that for biologically relevant interleukin (IL) derivatives including IL4, IL23, IL29, and IFG1. These molecules are also present along with IGFBP7 in the cell culture medium and have the potential to interfere with the analysis. Finally, the level secretion of IGFBP7 from cancer cells detected by the SPR biosensor showed a good correlation with a commercial kit using an IGFBP7 enzyme-linked immunosorbent assay. The findings reported herein indicate that the SPR biosensor for IGFBP7 would be applicable in a wide variety of biomedical fields.

KW - Cellular secretion

KW - IGFBP7

KW - Sensitive detection

KW - Specificity

KW - Surface plasmon resonance biosensor

UR - http://www.scopus.com/inward/record.url?scp=84915756611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915756611&partnerID=8YFLogxK

U2 - 10.1016/j.colsurfb.2014.10.037

DO - 10.1016/j.colsurfb.2014.10.037

M3 - Article

VL - 123

SP - 887

EP - 891

JO - Colloids and Surfaces B: Biointerfaces

JF - Colloids and Surfaces B: Biointerfaces

SN - 0927-7765

ER -